NOOSPHERE

Public document records

Bibliographic records with public provenance and stable links. The catalog does not include all documents in the corpus or reproduce their full texts.

98,186 public records · page 92 / 982

  1. Cannabis use disorder: an overview of treatment approaches in Europe2025 · Crossref
  2. Cannabis use experience of patients with chronic disease after revisions to the cannabis legalization regulations: a mixed-methods study in primary care settings in the south of Thailand2025 · Crossref
  3. Cannabis Use for Medical or Non-Medical Purposes in a Sample of Young Adult Cancer Survivors in the United States2025 · Crossref
  4. Cannabis use in adolescence and young adulthood and its effects on brain structure and function: a scoping review2025 · Crossref
  5. Cannabis Use in Adolescents2025 · Crossref
  6. Cannabis Use in California Following Legalization of Recreational Use2025 · Crossref
  7. Cannabis Use in Central Disorders of Hypersomnolence in the Netherlands2025 · Crossref
  8. Cannabis Use in Older Individuals May Be an Important and Under-Recognized Risk Factor for Motor Vehicle Crashes2025 · Crossref
  9. Cannabis Use in Opioid Maintenance Therapy: Prevalence, Clinical Correlates and Reasons for Use2025 · Crossref
  10. Cannabis Use in Women and Sexual Dysfunction2025 · Crossref
  11. Cannabis use is not associated with altered levels of physical activity: evidence from the repeated cross-sectional Belgian Health Interview Survey2025 · Crossref
  12. Cannabis use measurement: Identifying the optimal metric for broad research applications2025 · Crossref
  13. Cannabis Use Motives Associated with Mental Health Screening Among Older Adults2025 · Crossref
  14. Cannabis Use Patterns Among Adults Living With Chronic Pain Before and During the COVID Pandemic: Insights From the COVID‐19 Cannabis Health Study2025 · Crossref
  15. Cannabis Use Patterns and Blood Profiles in Adolescent Cannabinoid Hyperemesis Syndrome2025 · Crossref
  16. Cannabis Use Patterns and Co-Use of Alcohol and Nicotine in Adults Over 50 by Demographic Factors and Medical Cannabis Use2025 · Crossref
  17. Cannabis use patterns, motivations, and reasons for abstinence in pregnancy2025 · Crossref
  18. Cannabis use patterns, prevalence, and risk factors in Nigeria: a systematic review and meta-analysis2025 · Crossref
  19. Cannabis Use Trajectories Among People Living With HIV in the Decade Prior to Recreational Legalization in Ontario, Canada (2008-2017)2025 · Crossref
  20. Cannabis uso terapêutico em animais domésticos2025 · Crossref
  21. Cannabis, tabaco y coca: ¿psicodélicos, enteógenos o drogas? Problemas epistemológicos de las definiciones sobre estas sustancias2025 · OpenAlex
  22. Cannabis, Weight, and Weight-Related Behaviors2025 · Crossref
  23. Cannabis-Bacteria Interaction: Trends in Secondary Metabolites, Biocontrol, and By-products2025 · Crossref
  24. Cannabis-induced Catatonia: A Case Study2025 · Crossref
  25. Cannabis-involved Substance Use Treatment Admissions Age 50+, 2000-2021: Changes and Correlates2025 · Crossref
  26. Cannabis‐based products for medicinal use in dogs and cats: a systematic review2025 · Crossref
  27. Cannabis‐Derived Compounds Against Plasmodium sp.: A Systematic Review of Preclinical Studies2025 · OpenAlex
  28. Cantos xamânicos Huni Kuin: cerimônias de ayahuasca, cosmologias e pontes entre mundos2025 · OpenAlex
  29. CAPACITAÇÃO DE PROFISSIONAIS DE SAÚDE DO SUS SOBRE O USO TERAPÊUTICO DA CANNABIS E SEU IMPACTO NA PRÁTICA CLÍNICA2025 · Crossref
  30. Capitalist Development or Super‐exploitation? Exploring Divergent Patterns of Surplus Appropriation along Coffee Commodity Chains2025 · Crossref
  31. Caracterización Química de Inflorescencias de Cannabis No Psicoactivo (Cannabis sativa L.) de Ecuador2025 · Crossref
  32. Carbon footprint of Cannabis sativa L. cultivation under elevated ambient temperature conditions2025 · Crossref
  33. Carbon Materials in Voltammetry: An Overview of Versatile Platforms for Antidepressant Drug Detection2025 · OpenAlex
  34. Cardiac Assessment of Individuals with Opioid Use Disorder under Methadone Treatment2025 · Crossref
  35. Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine.2025 · PubMed
  36. Cardiological Aspects of Feeding and Eating Disorders in Children and Adolescents and Associations with Refeeding Syndrome, Purging Behaviors, and Psychoactive Drugs2025 · Crossref
  37. Cardiovascular and metabolic changes following 12 weeks of tobacco and nicotine pouch cessation: a Swedish cohort study2025 · Crossref
  38. Cardiovascular disease and chronic nicotine addiction: A qualitative analysis of smoking behaviour after post-cardiac event2025 · Crossref
  39. Cardiovascular disease risk prediction among people living with HIV in Uganda: A comparison of traditional statistical and machine learning models2025 · Crossref
  40. Cardiovascular Manifestations of Patients with Non-Alcoholic Fatty Liver Disease2025 · Crossref
  41. Cardiovascular Readmissions After Heart Failure: Substance Use Disorder as a Potential Risk Factor Among Psychiatric Comorbidities2025 · Crossref
  42. CARE PROVIDERS AND PATIENTS’ INSIGHTS ON IMPROVING SERVICE DELIVERY IN PUBLIC AND PRIVATE SUBSTANCE USE DISORDER TREATMENT CENTERS IN KADUNA, NORTHERN NIGERIA2025 · Crossref
  43. CARIES AND ORAL HEALTH-RELATED QUALITY OF LIFE IN PEOPLE WITH SUBSTANCE USE DISORDER (SUD) AT DRUG REHABILITATION CENTRE LIDO, INDONESIA2025 · Crossref
  44. CARÁCTER MIXTO DE LA DESTINACIÓN A UN TRATAMIENTO MÉDICO EN EL DELITO DE CULTIVO DE CANNABIS SATIVA CAUSA DE JUSTIFICACIÓN Y PRESUNCIÓN LEGAL2025 · Crossref
  45. Case Report: Cannabis and kratom-induced self-amputation of ears and penis2025 · Crossref
  46. Case Report: Intranasal esketamine combined with a form of generative artificial intelligence in the management of treatment-resistant depression2025 · OpenAlex
  47. Case Report: Multifocal Epithelial Hyperplasia in Two Yemeni Patients With Khat Chewing Habits2025 · OpenAlex
  48. Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis2025 · OpenAlex
  49. Case Report: Substance fixation in autism spectrum disorder with resultant anorexia nervosa2025 · Crossref
  50. Case Report: Successful management of psychogenic non-epileptic seizures with intranasal esketamine2025 · OpenAlex
  51. Case Report: Successful management of severe suicidal lamotrigine overdose-induced status epilepticus with sustained low-efficiency dialysis2025 · Crossref
  52. Case Study: Prototype Development of Coffee Cube – A Product Innovation in the Coffee Segment2025 · Crossref
  53. Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review2025 · OpenAlex
  54. Catalytic upgrading of hemp ( Cannabis sativa ) pyrolysis oil over CoMo/zeolite and in‐silico toxicity assessment2025 · Crossref
  55. Catastrophic Sequelae of Corneal Melt from Severe Active Thyroid Eye Disease in a Patient with Substance Use Disorder: A Case Report2025 · Crossref
  56. Catatonia induced by antipsychotics in an adolescent male patient with systemic lupus erythematosus: A case report2025 · OpenAlex
  57. Categorizing Stigma as a Barrier to Support Following Nonfatal Overdose: A Qualitative Study2025 · Crossref
  58. Causal factors of market demand affecting the growth and profitability of cannabis business2025 · Crossref
  59. Causal Inference in Studies with Functional Unmasking: Psychedelics and Beyond2025 · OpenAlex
  60. Causes of Drop Out in Substance Use Disorder Treatment: A Mixed-Method Study2025 · Crossref
  61. Cautions on the Notion of Moral Enhancement with Psychedelics. Reply to Kähönen, J. Subjective Effects of Psychedelics Are the Plausible Mechanism of Psychedelic Moral Enhancement Rather than a Risk. Comment on “Tang, B.L. Psychedelics for Moral Bioenhancement in Healthy Individuals—A Violation of the Non-Maleficence Principle? Psychoactives 2025, 4, 5”2025 · Crossref
  62. CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder – a randomized controlled trial2025 · Crossref
  63. CBD for pets: navigating quality assurance, safety standards, and marketing strategies2025 · Crossref
  64. Cell-Specific Vulnerability of Human Glioblastoma and Astrocytoma Cells to Mephedrone—An In Vitro Study2025 · OpenAlex
  65. Cell-type specific epigenetic and transcriptional mechanisms in substance use disorder2025 · Crossref
  66. CENTER-ing Black voices: incorporating lived experience across the research process to advance equity in drug treatment and outcomes2025 · OpenAlex
  67. Centering peers in design and training for a peer-delivered contingency management program for self-identified harm reduction and treatment goals2025 · Crossref
  68. Central Nervous System Stimulants in Recreational and Medical Use2025 · OpenAlex
  69. Centralized daily drug management in clinical trial institutions and specific implementation plans2025 · Crossref
  70. CERTAIN ASPECTS OF IMPROVING THE LEGAL AND ORGANIZATIONAL FRAMEWORK FOR THE APPOINTMENT AND CONDUCT OF FORENSIC EXAMINATIONS OF DRUGS IN THE INVESTIGATION OF OFFENSES RELATED TO ILLEGAL DRUG TRAFFICKING UNDER MARTIAL LAW2025 · Crossref
  71. Certain issues of forensic support for combating illegal drug trafficking2025 · Crossref
  72. Challenges and opportunities for Brazilian coffee cultivation arising from EU Regulation 2023/1115 (EUDR)2025 · Crossref
  73. Challenges and Opportunities for North Lombok Robusta Coffee2025 · Crossref
  74. Challenges Faced by Caregivers of Individuals With Substance Use Disorder in Pakistan: A Qualitative Study2025 · Crossref
  75. Challenges in Managing Depression in Clinical Practice: Result of a Global Survey2025 · OpenAlex
  76. Challenges of Drug Testing in Addiction Treatment2025 · Crossref
  77. Challenging linguicentrism in translation: a semiotic approach to the emergence of a female counterculture in digital spaces2025 · Crossref
  78. Change and sustained recovery in defense mechanisms and depression in a pilot study of antidepressant medications plus up to 18 months of psychotherapy for recurrent major depression2025 · Crossref
  79. Change in Cigarette, Other Tobacco Product, and Cannabis Use Among Individuals Who Used or Did Not Use Cannabis During a Smoking Cessation Trial2025 · Crossref
  80. Changes in Alcohol, Cannabis, and Tobacco Use Before and After the COVID-19 Pandemic in Adolescents in Catalonia: A Repeated Cross-Sectional Study2025 · Crossref
  81. Changes in alcohol‐related social network composition mediate the effects of AA meeting attendance on drinking following a recovery attempt in adults with alcohol use disorder2025 · Crossref
  82. Changes in and correlates of cannabis-involved substance use treatment admissions age 50 and older, 2000–20212025 · Crossref
  83. Changes in cannabis use post decriminalisation in mental health care users in South Africa2025 · Crossref
  84. Changes in Cannabis-Related Pediatric Emergency Visits following Recreational Marijuana Legalization in a New York City Hospital: A Retrospective Study2025 · Crossref
  85. Changes in health behaviour of medical students during and after the COVID-19 pandemic—focus on physical activity, screen time, sleep duration, unhealthy foods, alcohol, and tobacco2025 · Crossref
  86. Changes in Incident Schizophrenia Diagnoses Associated With Cannabis Use Disorder After Cannabis Legalization2025 · Crossref
  87. Changes in Local Community Spatial Trends of Motor Vehicle Accidents Near Cannabis Dispensaries after Recreational Cannabis Legalization2025 · Crossref
  88. Changes in population‐level alcohol sales after non‐medical cannabis legalisation in Canada2025 · Crossref
  89. Changes in prevalence of alcohol and tobacco consumption across districts of India, 2016 and 20212025 · Crossref
  90. Changes in recreational drug use, reasons for those changes and their consequence during and after the COVID-19 pandemic in the UK2025 · OpenAlex
  91. Changes in sleep quality among patients prescribed medicinal cannabis: Real-world evidence from Project Twenty 212025 · Crossref
  92. Changes in sleep quality during the 12 months following medical cannabis initiation2025 · Crossref
  93. Changes in Synthetic Opioid–Involved Youth Overdose Deaths in the United States: 2018–20222025 · OpenAlex
  94. Changes in the Sex/Gender Gap in Cannabis Use in Ontario, Canada From 2001 to 20192025 · Crossref
  95. Changes in the trajectories of drug-free friendships and substance use among a cohort of individuals with multiple substance use disorders2025 · Crossref
  96. Changes in tobacco use in rural South Africa during the 2020 tobacco sales ban: an analysis of current and previous behaviours using cross-sectional data2025 · Crossref
  97. Changes over time in novel benzodiazepines contributing to fatal overdoses in Victoria, Australia2025 · OpenAlex
  98. Changes to Personal Social Media Accounts and Use Among Those With Substance Use Disorder Who Are Currently in Treatment: A Cross-sectional Survey2025 · Crossref
  99. Changing Advanced Practice Nursing Students’ Attitudes, Perceptions, and Stigma Through Substance Use Enhanced Core Courses: An Exploratory Descriptive Study2025 · Crossref
  100. Changing age profile and incidence of injecting drug use initiation among people in Australia who inject drugs: evidence from two national repeated cross-sectional studies2025 · OpenAlex